Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection

BACKGROUND: Despite advances in antiretroviral therapy (ART), people living with human immunodeficiency virus (HIV) continue to be at increased risk of cardiometabolic complications compared to HIV-uninfected individuals. Advanced glycation end products (AGEs) are implicated in the development and p...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kamari, Vanessa, Rodriguez, Katherine, Moser, Carlee, Currier, Judith S, Kelesidis, Theodoros, Stein, James H, Brown, Todd T, Howell, Scott K, Beisswenger, Paul J, McComsey, Grace A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496763/
https://www.ncbi.nlm.nih.gov/pubmed/34631914
http://dx.doi.org/10.1093/ofid/ofab423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496763/
https://www.ncbi.nlm.nih.gov/pubmed/34631914
http://dx.doi.org/10.1093/ofid/ofab423

Ejemplares similares